NANJING KING-FRIEND BIOCHEMICAL PHARMACEUTICAL CO.,LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13.7 CNY | +5.14% |
|
+3.47% | -8.67% |
| 05-01 | NKFPharma Gets Nod to Register New Cancer Treatment | MT |
| 04-27 | Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bearish | Bearish |
| Resistance | 13.75 | 13.75 | 13.79 |
| Spread/Res. | -0.36% | -0.36% | -0.65% |
| Spread/Supp. | +12.48% | +23.76% | +22.21% |
| Support | 12.18 | 11.07 | 11.21 |
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- 603707 Stock
- Charts Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd.
